Physician profile
Sudhir Batchu
NPI 1871698662
$4,950.57
in general payments reported to CMS, 2019-2025
43 companies · $268 in 2025
The $268 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,006 · 2020: $1,848 · 2021: $348 · 2022: $37.33 · 2023: $22.29 · 2024: $421 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $841.09 | 2019-2021 | |
| Genzyme Corporation | $614.14 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $588.81 | 2019-2024 | |
| Ucb, INC. | $316.21 | 2019-2025 | Nayzilam |
| Biogen, INC. | $292.65 | 2019-2021 | |
| Amgen INC. | $208.99 | 2019-2021 | |
| Lilly USA, LLC | $183.49 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $159.04 | 2019-2025 | |
| Pfizer INC. | $153.33 | 2019-2025 | |
| Emd Serono, INC. | $138.27 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $120.53 | 2019-2024 | Austedo Xr |
| Alexion Pharmaceuticals, INC. | $120.44 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $94.87 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $88.01 | 2019-2020 | |
| Harmony Biosciences LLC | $87.42 | 2024 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sudhir Batchu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.